Menu
Recruiting NCT04566744

NeuroCognitive Bases of Tool Use

No phase Interventional Healthy

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: fRMI.
Who it may be relevant to
Registry conditions: Healthy. Basic parameters: 18 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Tool use is considered to be the hallmark of complex cognitive adaptations that humans have achieved trough evolution, that provides an adaptive advantage to the human species. Even if nonhuman species do use tools too, human tool use is much more complex and sophisticated. If humans have special abilities for tool use, it has to be grounded in a specific neuroanatomical substrate. Humans and nonhumans share a similar prehension system located within the superior parietal lobe and the intraparietal sulcus. However, there is a human specificity: the supramarginal gyrus within the left inferior parietal lobe is unique to humans, and could play a central role in tool use. This project aims to study the neurocognitive bases of human tool use with functional Magnetic Resonance Imaging (fMRI), to precise the cognitive mechanisms through which humans are able to use tools.

Interventions

  • Other fRMI
    The measurements performed will be the participant's brain activity, as well as behavioral measurements associated with the tasks performed (response time, correctness of the response). Brain activity measurements will be performed on the Siemens 3T system of the MRI department of CERMEP. The subject will perform the task under study while the level of brain activity is recorded. The functional examination will be subdivided into several parts according to its total length in order to spare the

Primary outcome measures

  • Blood Oxygenation Level Dependent measure [Time frame: 1 hour]

Eligibility criteria

Inclusion criteria

  • To be between the ages of 18 and 65 years old
  • Having given an informed consent for the study

Exclusion criteria

  • Pregnant or breastfeeding woman
  • Persons under curators or deprived of civil rights or deprived of their freedom
  • Not being registered with the French Social Security System
  • Not able to read/write the French
  • Neurologic or psychiatric illness, known or revealed during the inclusion visit
  • Substance intake ( taking psychoactive medications or recreational drugs) on the day of the experiment
  • Noise intolerance
  • Unable to fill a questionnaire (severe cognitive troubles)
  • Not willing that their personal doctor to be informed in case of a MRI anomaly.
  • Not willing to be informed in case of MRI anomaly
  • Subjects must not have metallic or electronic implants in the body : pacemakers or pacemaker wires, open heart surgery, artificial heart valve, brain aneurysm surgery, middle ear implant, hearing aid, braces or extensive dental work, cataract surgery or lens implant, implanted mechanical or electrical device, or artificial limb or joint o foreign metallic objects in the body (bullets, pellets, shrapnel, or metalwork fragments) or current or past employment as machinists, welders or metal workers, tattoos near the head or neck regions, permanent makeup
  • Not willing to complete the study
  • Appearance of a exclusion criterion during the protocol
  • Appearance of an undesirable event preventing the completion of the protocol
  • Too great head movements (>4mm for the session)
  • Detection of artifacts in the brain images collected

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Non-randomized
Model
Single group
Masking
Open label
Primary purpose
Basic science

Study locations

France · 1 center
  • CERMEP — Bron

Identifiers

NCT: NCT04566744 · 69HCL20_0677 · 2020-A02115-34

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗